Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel Approaches

Advances in multimodal immunotherapy have significantly reduced acute rejection rates and substantially improved 1-year graft survival following renal transplantation. However, long-term (10-year) survival rates have stagnated over the past decade. Recent studies indicate that antibody-mediated reje...

Descripción completa

Detalles Bibliográficos
Autores principales: Djamali, A, Kaufman, D B, Ellis, T M, Zhong, W, Matas, A, Samaniego, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Comprehensive Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285166/
https://www.ncbi.nlm.nih.gov/pubmed/24401076
http://dx.doi.org/10.1111/ajt.12589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285166/
https://www.ncbi.nlm.nih.gov/pubmed/24401076
http://dx.doi.org/10.1111/ajt.12589

Ejemplares similares